298 related articles for article (PubMed ID: 27458165)
1. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
Li H; Li X; Ge X; Jia L; Zhang Z; Fang R; Yang J; Liu J; Peng S; Zhou M; Xiang J; Zeng Z; Zhou W; Xiong W; Xiao G; Fang L; Li GY; Li Z
Oncotarget; 2016 Aug; 7(34):54838-54851. PubMed ID: 27458165
[TBL] [Abstract][Full Text] [Related]
2. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
3. miR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation.
Li L; Liu H; Du L; Xi P; Wang Q; Li Y; Liu D
Oncol Res; 2018 May; 26(4):547-556. PubMed ID: 28800787
[TBL] [Abstract][Full Text] [Related]
4. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
5. miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.
Hu S; Jiang Q; Luo D; Zhao L; Fu X; Chen Y; Song X; Li L; Zhao H; He Y; Peng B
Oncotarget; 2016 Jul; 7(30):48423-48431. PubMed ID: 27374173
[TBL] [Abstract][Full Text] [Related]
6. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
Li L; Kang L; Zhao W; Feng Y; Liu W; Wang T; Mai H; Huang J; Chen S; Liang Y; Han J; Xu X; Ye Q
Cancer Lett; 2017 Aug; 400():89-98. PubMed ID: 28461244
[TBL] [Abstract][Full Text] [Related]
7. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
Zheng XM; Xu CW; Wang F
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):31-35. PubMed ID: 30213286
[TBL] [Abstract][Full Text] [Related]
8. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.
Liu J; Chen W; Chen Z; Wen J; Yu H; Wang F; Wu L; He X
Biomed Pharmacother; 2017 Sep; 93():869-878. PubMed ID: 28724212
[TBL] [Abstract][Full Text] [Related]
9. MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA.
Chen H; Gao S; Cheng C
Hum Cell; 2018 Oct; 31(4):300-309. PubMed ID: 30088225
[TBL] [Abstract][Full Text] [Related]
10. [miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].
Deng M; Liu JF; Gu YX; Zheng GP; He ZM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):645-50. PubMed ID: 24332049
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma.
Qi X; Li J; Zhou C; Lv C; Tian M
FEBS Lett; 2014 Oct; 588(20):3732-8. PubMed ID: 25171860
[TBL] [Abstract][Full Text] [Related]
12. miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.
Han RL; Wang FP; Zhang PA; Zhou XY; Li Y
Neoplasma; 2017; 64(2):244-252. PubMed ID: 28043152
[TBL] [Abstract][Full Text] [Related]
13. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.
Alajez NM; Lenarduzzi M; Ito E; Hui AB; Shi W; Bruce J; Yue S; Huang SH; Xu W; Waldron J; O'Sullivan B; Liu FF
Cancer Res; 2011 Mar; 71(6):2381-91. PubMed ID: 21385904
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
Li X; Zhao H; Zhou X; Song L
Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
[TBL] [Abstract][Full Text] [Related]
15. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma.
He Y; Chen X; Yu Y; Li J; Hu Q; Xue C; Chen J; Shen S; Luo Y; Ren F; Li C; Bao J; Yan J; Qian G; Ren Z; Sun R; Cui G
Mol Carcinog; 2018 Jun; 57(6):772-783. PubMed ID: 29569755
[TBL] [Abstract][Full Text] [Related]
16. MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma.
Niu M; Gao D; Wen Q; Wei P; Pan S; Shuai C; Ma H; Xiang J; Li Z; Fan S; Li G; Peng S
BMC Cancer; 2016 Mar; 16():218. PubMed ID: 26975503
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells.
Pan X; Peng G; Liu S; Sun Z; Zou Z; Wu G
Int J Mol Med; 2015 Aug; 36(2):559-64. PubMed ID: 26081980
[TBL] [Abstract][Full Text] [Related]
18. miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.
Zhang Q; Li Q; Xu T; Jiang H; Xu LG
Oncol Rep; 2016 Jun; 35(6):3541-7. PubMed ID: 27035429
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
[TBL] [Abstract][Full Text] [Related]
20. miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.
Yan HL; Li L; Li SJ; Zhang HS; Xu W
J Biochem Mol Toxicol; 2016 Dec; 30(12):602-607. PubMed ID: 27501413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
